Sensei biotherapeutics to present at oppenheimer 31st annual virtual healthcare conference

Boston and rockville, md., march 09, 2021 (globe newswire) -- sensei biotherapeutics, inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that john celebi, president and chief executive officer of sensei biotherapeutics, will present at the oppenheimer 31st annual virtual healthcare conference on tuesday, march 16th, 2021 at 9:20 a.m. et.
SNSE Ratings Summary
SNSE Quant Ranking